Tamim Niazi, MD, McGill University, Montreal, Quebec, Canada, discusses the key personal highlights of ASTRO 2022 which include developments in artificial intelligence and key clinical trial data impacting clinical practice. This interview took place at the American Society for Radiation Oncology (ASTRO) 2022 Congress in San Antonio, Tx.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.